Depression

updated.gif08/02/2017


RAP-MD-03 Study

 We are currently enrolling participants in a clinical research study to evaluate the effectiveness and safety of an investigational drug.  The study will examine if the study drug can treat symptoms of a major depressive episode while a person is on a stable dose of another antidepressant therapy.

Participants must: 

  • be 18 to 65 years of age
  • have been diagnosed with depression
  • be experiencing current symptoms of depression despite      taking an antidepressant medication
  • must be comfortable receiving IV medication
  • not be pregnant or have plans to become pregnant

Subjects will receive study drug and study-related care at no cost.  Study participation will last up to 5 weeks, and then subjects will potentially be able to enroll in long-term follow-up studies afterward. Compensation for time and travel will be provided for qualified participants.

Contact Chelsea Kosma @ 508-856-5312

WIRB #16058840.0


The Depression Relapse Trial

Individuals that are currently suffering from depression are invited to participate in a research study to determine the effectiveness and safety of vortioxetine in preventing relapse in depression for those subjects who respond to treatment with vortioxetine. Study participation will last up to 55 weeks and subjects will receive the study drug vortioxetine.

Participants must be: 

  • 18 to 75 years of age
  • suffering from recurrent Major Depressive Disorder
  • experiencing current symptoms of depression
  • not be pregnant or have plans to become pregnant

Subjects will receive study drug and study-related care at no cost. Compensation provided.

Contact Michelangela Yusif @ 774-455-4136

Docket #H-00007086  


 ESKETINTRD3001 Study - RECRUITMENT CLOSED

We are currently enrolling participants in a clinical research study to look at the effectiveness and safety of an investigational medication (given as a nasal spray) in patients with depression who have not responded to prior treatment with an antidepressant and currently taking a different antidepressant. 

Participants must: 

  • be 18 to 64 years of age
  • have been diagnosed with depression
  • be experiencing current symptoms of depression despite      taking antidepressant medications
  • have not responded to prior treatment with an      antidepressant and currently taking a different antidepressant
  • must be comfortable with using a nasal spray
  • not be pregnant or have plans to become pregnant

Subjects will receive study drug and study-related care at no cost.  Study participation will last up to 35 weeks. Compensation for time and travel will be provided for qualified participants.

Contact Chelsea Kosma @ 508-856-5312

Docket #H-00011026

 


back to top